Evidence map›Paper›PMID 24595242›Full record

ArticleInternational journal of molecular sciences2014

Role of A20 in cIAP-2 protection against tumor necrosis factor α (TNF-α)-mediated apoptosis in endothelial cells.

Shuzhen Guo, Angela F Messmer-Blust, Jiaping Wu, Xiaoxiao Song, Melissa J Philbrick, Jue-Lon Shie, Jamal S Rana, Jian Li

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Endothelial c-IAP2 loss amplifies P2X7 receptor-driven inflammation and worsens schistosomiasis-associated pulmonary hypertension.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Frontiers in pharmacology · 2021
    Article
  4. [Endoplasmic reticulum stress enhances tumor necrosis factor-Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  5. Kupffer Cell-Derived TNF-BioMed research international · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Shuzhen GuoSchool of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. guoshz@bucm.edu.cn.
Angela F Messmer-BlustCardioVascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. angela.messmerblust@gmail.com.
Jiaping WuCardioVascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. wujiaping@hotmail.com.
Xiaoxiao SongCardioVascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. xsong103@gmail.com.
Melissa J PhilbrickCardioVascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. mphilbric@gmail.com.
Jue-Lon ShieCardioVascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. shiejuelon66@yahoo.com.
Jamal S RanaCardioVascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. jamalrana@gmail.com.
Jian LiCardioVascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. jianliboston@gmail.com.
Beth Israel Deaconess Medical Center · US

Funding

The Role of RTEF-1 in Angiogenesis and Myocardial IschemiaR01HL082837 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LI, JIAN · 2007 to 2011
$2.4M
Survivin in Endothelial HyperglycemiaR21HL088219 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LI, JIAN · 2008 to 2009
$425k
NHLBI NIH HHS R01 HL082837NHLBI NIH HHS R01HL082837NHLBI NIH HHS R21 HL088219NHLBI NIH HHS R21HL088219
6 · The paper itself

Abstract

Tumor necrosis factor α (TNF-α) influences endothelial cell viability by altering the regulatory molecules involved in induction or suppression of apoptosis. However, the underlying mechanisms are still not completely understood. In this study, we demonstrated that A20 (also known as TNFAIP3, tumor necrosis factor α-induced protein 3, and an anti-apoptotic protein) regulates the inhibitor of apoptosis protein-2 (cIAP-2) expression upon TNF-α induction in endothelial cells. Inhibition of A20 expression by its siRNA resulted in attenuating expression of TNF-α-induced cIAP-2, yet not cIAP-1 or XIAP. A20-induced cIAP-2 expression can be blocked by the inhibition of phosphatidyl inositol-3 kinase (PI3-K), but not nuclear factor (NF)-κB, while concomitantly increasing the number of endothelial apoptotic cells and caspase 3 activation. Moreover, TNF-α-mediated induction of apoptosis was enhanced by A20 inhibition, which could be rescued by cIAP-2. Taken together, these results identify A20 as a cytoprotective factor involved in cIAP-2 inhibitory pathway of TNF-α-induced apoptosis. This is consistent with the idea that endothelial cell viability is dependent on interactions between inducers and suppressors of apoptosis, susceptible to modulation by TNF-α.

Indexed as

AnimalsApoptosisBaculoviral IAP Repeat-Containing 3 ProteinBlotting, WesternCaspase 3CattleCells, CulturedChromonesDNA-Binding ProteinsDose-Response Relationship, DrugEndothelial CellsGene ExpressionHEK293 CellsHumansInhibitor of Apoptosis ProteinsIntracellular Signaling Peptides and Proteins2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneBaculoviral IAP Repeat-Containing 3 ProteinBIRC3 protein, humanCaspase 3ChromonesDNA-Binding ProteinsInhibitor of Apoptosis ProteinsIntracellular Signaling Peptides and ProteinsMorpholinesNuclear ProteinsPhosphatidylinositol 3-KinasePhosphoinositide-3 Kinase InhibitorsTNFAIP3 protein, humanTumor Necrosis Factor-alphaTumor Necrosis Factor alpha-Induced Protein 3Ubiquitin-Protein Ligases

Identifiers

PMID24595242
PMCPMC3975369
OpenAlexW2065526129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.